Conference Coverage: European Hematology Association (EHA): Annual Congress

Conference Coverage

Midostaurin improves survival in new AML

Adding the multitargeted kinase inhibitor midostaurin to standard chemotherapy led to significantly longer overall and event-free survival...

Pages